GUIDELINER TELEFLEX FREE

GUIDELINER TELEFLEX FREE

In this very complicated cohort, technical success (defined as successful guidewire recanalization) was achieved in 93.3% of cases, and procedural success (i.e., free of major adverse cardiovascular events, MACE) was achieved in over 75% of cases. GuideLiner Catheters are intended to be used in conjunction with guide catheters to access discrete regions of the coronary and/or peripheral vasculature, and to facilitate placement of interventional devices. GuideLiner Catheters are intended to be used in conjunction with guide catheters to access discrete regions of the coronary and/ or peripheral vasculature. These products were evaluated as part of the CTO-PCI study, a peer-reviewed, prospective, single-arm IDE study that enrolled 150 patients across 13 investigational centers across the United States. Now in its third generation, the GuideLiner V3 Catheter continues to build on a history of innovation and performanceone that's been demonstrated with more than half a million catheters in cath labs around. Approximately 57,000 CTO interventions are performed annually in the US.ĭevices receiving the expanded indication include the Teleflex GuideLiner V3 Catheter, TrapLiner Catheter, Turnpike Catheters, Spectre Guidewire, Raider Guidewire, Bandit Guidewire, Warrior Guidewire, and R350 Guidewire. In 2009, the GuideLiner Catheter revolutionized the concept of guide extension, creating new possibilities in interventional cardiology. For more information about the GuideLiner ® V3 Catheter.

Often a source of limiting symptoms, CTOs may also contribute to cardiac dysfunction and are associated with poor prognosis. The GuideLiner ® V3 Catheter will be featured in Teleflex booth 1251 at TCT 2019, September 25-29 at the Moscone Center in San Francisco. Importantly, clinically significant CTOs are found in nearly 20% of patients undergoing diagnostic coronary angiography for suspected ischemic heart disease. GuideLiner (Teleflex), 297 69 for Guidezilla (Boston Scientific), 47 (11) TrapLiner (Teleflex) and, 26 6 for Telescope (Medtronic). Food and Drug Administration (FDA) has cleared an expanded indication for its specialty catheters and coronary guidewires for use in crossing chronic total occlusion percutaneous coronary interventions (CTO PCI).ĬTOs are longstanding complete blockages in coronary arteries that result in profound regional reduction of coronary blood flow (ischemia). Teleflex Incorporated, announced in a press release that the U.S.

Guideliner teleflex